Forbes India: How the Abbott-Piramal Deal Went Down

Sandoz breaks ground on $440M biosimilar manufacturing site in Slovenia

Simtra BioPharma adds injectable manufacturing capacity in Germany

FDA hits Unicycive with CRL due to third-party manufacturing issues

Axplora to invest $38M to expand API manufacturing site in Italy